Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ramalho MCC"'
Publikováno v:
In Hematology, Transfusion and Cell Therapy October 2024 46 Supplement 4:S360-S360
Autor:
Souza, CS, Sampaio, SSC, Ramalho, MCC, Mendonça, GRS, Duarte, ASS, Saad, STO, Rocha, CRR, Lazarini, M
Publikováno v:
In Hematology, Transfusion and Cell Therapy October 2024 46 Supplement 4:S356-S356
Autor:
de Castro Sampaio SS; Department of Clinical and Experimental Oncology, Federal University of São Paulo, São Paulo, Brazil., Ramalho MCC; Department of Clinical and Experimental Oncology, Federal University of São Paulo, São Paulo, Brazil., de Souza CS; Department of Clinical and Experimental Oncology, Federal University of São Paulo, São Paulo, Brazil., de Almeida Rodrigues B; Department of Clinical and Experimental Oncology, Federal University of São Paulo, São Paulo, Brazil., de Mendonça GRS; Department of Clinical and Experimental Oncology, Federal University of São Paulo, São Paulo, Brazil., Lazarini M; Department of Clinical and Experimental Oncology, Federal University of São Paulo, São Paulo, Brazil.
Publikováno v:
Journal of cellular physiology [J Cell Physiol] 2024 Oct 21, pp. e31469. Date of Electronic Publication: 2024 Oct 21.
Autor:
Teixeira ABDS; Universidade Federal de São Paulo (UNIFESP), Departamento de Oncologia Clínica e Experimental, São Paulo, SP, Brazil., Ramalho MCC; Universidade Federal de São Paulo (UNIFESP), Departamento de Oncologia Clínica e Experimental, São Paulo, SP, Brazil., Souza I; Universidade Federal de São Paulo (UNIFESP), Departamento de Oncologia Clínica e Experimental, São Paulo, SP, Brazil., Andrade IAM; Universidade Federal de São Paulo (UNIFESP), Departamento de Oncologia Clínica e Experimental, São Paulo, SP, Brazil., Osawa IYA; Universidade Federal de São Paulo (UNIFESP), Departamento de Oncologia Clínica e Experimental, São Paulo, SP, Brazil., Guedes CB; Universidade Federal de São Paulo (UNIFESP), Departamento de Oncologia Clínica e Experimental, São Paulo, SP, Brazil., Oliveira BS; Universidade Federal de São Paulo (UNIFESP), Departamento de Oncologia Clínica e Experimental, São Paulo, SP, Brazil., Souza Filho CHD; Universidade Federal de São Paulo (UNIFESP), Departamento de Oncologia Clínica e Experimental, São Paulo, SP, Brazil., Silva TLD; Universidade Federal de São Paulo (UNIFESP), Departamento de Oncologia Clínica e Experimental, São Paulo, SP, Brazil., Moreno NC; National Institutes of Health, National Institute of Child Health and Human Development, Laboratory of Genomic Integrity, Bethesda, MD, USA., Latancia MT; National Institutes of Health, National Institute of Child Health and Human Development, Laboratory of Genomic Integrity, Bethesda, MD, USA., Rocha CRR; Universidade Federal de São Paulo (UNIFESP), Departamento de Oncologia Clínica e Experimental, São Paulo, SP, Brazil.
Publikováno v:
Genetics and molecular biology [Genet Mol Biol] 2024 May 31; Vol. 47 (Suppl 1), pp. e20230317. Date of Electronic Publication: 2024 May 31 (Print Publication: 2024).
Autor:
Almeida Lima K; Department of Clinical and Experimental Oncology, Federal University of Sao Paulo (UNIFESP), Sao Paulo 04037-003, Brazil., Osawa IYA; Department of Clinical and Experimental Oncology, Federal University of Sao Paulo (UNIFESP), Sao Paulo 04037-003, Brazil., Ramalho MCC; Department of Clinical and Experimental Oncology, Federal University of Sao Paulo (UNIFESP), Sao Paulo 04037-003, Brazil., de Souza I; Department of Clinical and Experimental Oncology, Federal University of Sao Paulo (UNIFESP), Sao Paulo 04037-003, Brazil., Guedes CB; Department of Clinical and Experimental Oncology, Federal University of Sao Paulo (UNIFESP), Sao Paulo 04037-003, Brazil., Souza Filho CHD; Department of Clinical and Experimental Oncology, Federal University of Sao Paulo (UNIFESP), Sao Paulo 04037-003, Brazil., Monteiro LKS; Department of Clinical and Experimental Oncology, Federal University of Sao Paulo (UNIFESP), Sao Paulo 04037-003, Brazil., Latancia MT; Laboratory of Genomic Integrity, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892-3371, USA., Rocha CRR; Department of Clinical and Experimental Oncology, Federal University of Sao Paulo (UNIFESP), Sao Paulo 04037-003, Brazil.
Publikováno v:
Biomedicines [Biomedicines] 2023 Apr 03; Vol. 11 (4). Date of Electronic Publication: 2023 Apr 03.
Autor:
de Souza I; Department of Clinical and Experimental Oncology, Federal University of Sao Paulo (UNIFESP), Sao Paulo 04037-003, Brazil., Ramalho MCC; Laboratory of Cell Cycle, Center of Toxins, Immune Response and Cell Signaling (CeTICS), Butantan Institute, Sao Paulo 05503-001, Brazil., Guedes CB; Department of Clinical and Experimental Oncology, Federal University of Sao Paulo (UNIFESP), Sao Paulo 04037-003, Brazil., Osawa IYA; Laboratory of Cell Cycle, Center of Toxins, Immune Response and Cell Signaling (CeTICS), Butantan Institute, Sao Paulo 05503-001, Brazil., Monteiro LKS; Department of Clinical and Experimental Oncology, Federal University of Sao Paulo (UNIFESP), Sao Paulo 04037-003, Brazil., Gomes LR; Laboratory of Cell Cycle, Center of Toxins, Immune Response and Cell Signaling (CeTICS), Butantan Institute, Sao Paulo 05503-001, Brazil., Rocha CRR; Department of Clinical and Experimental Oncology, Federal University of Sao Paulo (UNIFESP), Sao Paulo 04037-003, Brazil.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2022 Jun 21; Vol. 23 (13). Date of Electronic Publication: 2022 Jun 21.